Oncology and complications

Published: March 19, 2021
Abstract Views: 1785
PDF: 1089
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


This collection of cases describes some unusual urological tumors and complications related to urological tumors and their treatment.

Case 1: A case of uretero-arterial fistula in a patient with long-term ureteral stenting for ureteral oncological stricture and a second case associated to retroperitoneal fibrosis were described. Abdominal CT, pyelography, cystoscopy were useful to show the origin of the bleeding. Angiography is useful for confirming the diagnosis and for subsequent positioning of an endovascular prosthesis which represents a safe approach with reduced post-procedural complications.

Case 2: A case of patient who suffered from interstitial pneumonitis during a cycle of intravesical BCG instillations for urothelial cancer. The patient was hospitalized for more than two weeks in a COVID ward for a suspected of COVID-19 pneumonia, but he did not show any evidence of SARS-CoV-2 infection during his hospital stay.

Case 3: A case of a young man with a functional urinary bladder paraganglioma who was successfully managed with complete removal of the tumor, leaving the urinary bladder intact.

Case 4: A case of a 61 year old male suffering from muscle invasive bladder cancer who was admitted for a radical cystectomy and on the eighth postoperative day developed microangiopathic hemolytic anemia and thrombocytopenia, which clinically defines thrombotic microangiopathy.



PlumX Metrics


Download data is not yet available.


Moschowitz A. Simultaneous ligation of both external iliac arteries for secondary hemorrhage following bilateral ureterolithotomy. Ann Surg. 1908; 48:872-5. DOI: https://doi.org/10.1097/00000658-190812000-00009
Van den Bergh RC, Moll FL, de Vries JP, et al. Arterioureteral fistulas: unusual suspects systematic review of 139 cases. Urology. 2009; 74:251-5. DOI: https://doi.org/10.1016/j.urology.2008.12.011
Krambeck AE, DiMarco DS, Gettman MT, et al. Ureteroiliac artery fistula: diagnosis and treatment algorithm. Urology. 2005;66:990-4. DOI: https://doi.org/10.1016/j.urology.2005.05.036
Fox JA, Krambeck A, McPhail EF, et al. Ureteroarterial fistula treatment with open surgery versus endovascular management: long-term outcomes. J Urol. 2011; 185:945-50. DOI: https://doi.org/10.1016/j.juro.2010.10.062
Arts RJW, et al. BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity. Cell Host Microbe. 2018; 23:89-100.e5. DOI: https://doi.org/10.1016/j.chom.2017.12.010
Malmstrom PU, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for nonmuscleinvasive bladder cancer. Eur Urol. 2009; 56:247. DOI: https://doi.org/10.1016/j.eururo.2009.04.038
Redelman-Sidi G, Glickman MS, Bochner BH. The mechanism of action of BCG therapy for bladder cancer-a current perspective. Nat Rev Urol. 2014; 11:153-162. DOI: https://doi.org/10.1038/nrurol.2014.15
Leestma JE, Price EB Jr. Paraganglioma of the urinary bladder. Cancer. 1971; 28:1063-73. DOI: https://doi.org/10.1002/1097-0142(1971)28:4<1063::AID-CNCR2820280433>3.0.CO;2-R
Al-Zahrani AA. Recurrent urinary bladder paraganglioma. Adv Urol. 2010; 2010:912125. DOI: https://doi.org/10.1155/2010/912125
Peng C, Bu S, Xiong S, et al. Non-functioning paraganglioma occurring in the urinary bladder: A case report and review of the literature. Oncol Lett. 2015; 10: 321-324. DOI: https://doi.org/10.3892/ol.2015.3222
Lenders JW, Duh QY, Eisenhofer G, et al. Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014; 99:1915-42. DOI: https://doi.org/10.1210/jc.2014-1498
Eskazan AE, Buyuktas D, Soysal T. Postoperative thrombotic thrombocytopenic purpura. Surg Today. 2015; 45:8-16. DOI: https://doi.org/10.1007/s00595-013-0823-y
Scully M, Goodship T. How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome. Br J Haematol. 2014; 164:759-66. DOI: https://doi.org/10.1111/bjh.12718

How to Cite

Giordano, G. ., Kyriazi, E. ., Mavridis, C. ., Persico, F. ., Fragkoulis, C. ., Gatto, P. ., Georgiadis, G. ., Giagourta, I. ., Glykas, I. ., Hurle, R. ., Lazzeri, M. ., Lughezzani, G., Magnano San Lio, V. ., Mamoulakis, C. ., Meo , D. ., Papadaki, H. A. ., Piaditis, G. ., Pontikoglou, C. ., & Stathouros, G. . (2021). Oncology and complications. Archivio Italiano Di Urologia E Andrologia, 93(1), 71–76. https://doi.org/10.4081/aiua.2021.1.71